Stanford University
Showing 211-220 of 627 Results
-
Talayeh Ghezelayagh
Instructor, Obstetrics & Gynecology - Gynecologic Oncology
BioTalayeh Ghezelayagh, M.D., M.P.H, is an Instructor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology at Stanford University School of Medicine. She received her medical degree from the University of San Francisco, CA School of Medicine and earned a master’s in public health at the Harvard T.H. Chan School of Public Health. She then completed residency in obstetrics and gynecology and a fellowship in gynecologic oncology at the University of Washington.
Dr. Ghezelayagh’s research focuses on improving cancer risk predictions and health outcomes in patients at increased familial or genetic risk of gynecologic cancers. She is a clinically active gynecologic oncologist but spends much of her clinical work counseling and treating patients at higher risk for developing gynecologic cancers. -
Chandrayee Ghosh
Affiliate, Surgery - General Surgery
BioChandrayee Ghosh, PhD, is a Basic Life Research Scientist in the Department of Surgery at Stanford University School of Medicine and has been working in the field of Cancer and Immunology, with specific training and expertise in cancer therapeutics and translational science pertaining to drug repurposing and novel formulations of natural compounds. She has authored and coauthored 9 peer reviewed original articles in high impact journals. Her work has received media coverage both nationally and internationally. She presented her works in more than 18 international conferences and is recipient of research awards for her work. Her scientific contribution includes ground breaking findings such as identifying novel functions of FDA approved compounds and their combinations in targeting and assessing their mechanism of actions in one of the deadliest endocrine cancers anaplastic thyroid cancer, discovery of the interaction KDM3A with DCLK-1 and their role in pancreatic ductal adenocarcinoma tumorigenesis and stemness, identifying the cluster of master transcription factors or Super-Enhancers as novel targets for pancreatic cancer using novel formulation of natural compounds as anticancer agents.
-
Amato J. Giaccia
Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsDuring the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.
